EBV+ and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8+ Intratumoral Lymphocytes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EBV+ and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8+ Intratumoral Lymphocytes
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 4, Pages 102
Publisher
MDPI AG
Online
2018-04-03
DOI
10.3390/cancers10040102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD274 (PDL1 ) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients
- (2017) Sergi Clavé et al. HISTOPATHOLOGY
- Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability
- (2016) Changqing Ma et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Dual Faces of IFN in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
- (2016) M. Mandai et al. CLINICAL CANCER RESEARCH
- Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
- (2016) C.-Y. Ock et al. CLINICAL CANCER RESEARCH
- Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients
- (2016) Akihito Kawazoe et al. Gastric Cancer
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
- (2016) Elizabeth D Thompson et al. GUT
- PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer
- (2016) Zhongwu Li et al. HUMAN PATHOLOGY
- PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
- (2016) Christine Böger et al. Oncotarget
- Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group
- (2016) Hyeyoon Chang et al. Oncotarget
- Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
- (2016) Sarah Derks et al. Oncotarget
- The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients
- (2016) Minghui Zhang et al. Scientific Reports
- Guidelines for cytogenetic investigations in tumours
- (2015) Rosalind J Hastings et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection
- (2015) Shohei Eto et al. Gastric Cancer
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities
- (2013) Barbara Merelli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition
- (2013) A. Simons et al. CYTOGENETIC AND GENOME RESEARCH
- Histotype-based prognostic classification of gastric cancer
- (2012) Anna Maria Chiaravalli WORLD JOURNAL OF GASTROENTEROLOGY
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
- (2010) J.-J. Park et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started